147 related articles for article (PubMed ID: 2787634)
1. Transforming growth factor-beta causes partial inhibition of interleukin 1-stimulated cartilage degradation in vitro.
Andrews HJ; Edwards TA; Cawston TE; Hazleman BL
Biochem Biophys Res Commun; 1989 Jul; 162(1):144-50. PubMed ID: 2787634
[TBL] [Abstract][Full Text] [Related]
2. Modulation by transforming growth factor-beta 1 and interleukin-1 beta of proteoglycan release and chondrodisaccharide composition in porcine articular cartilage.
Zanni M; Tamburro A; Santone I; Rotilio D
Semin Thromb Hemost; 1994; 20(2):159-67. PubMed ID: 7997887
[TBL] [Abstract][Full Text] [Related]
3. The recovery of articular cartilage in explant culture from interleukin-1 alpha: effects on proteoglycan synthesis and degradation.
Rayan V; Hardingham T
Matrix Biol; 1994 Apr; 14(3):263-71. PubMed ID: 7921543
[TBL] [Abstract][Full Text] [Related]
4. Independent effects of interleukin 1 on proteoglycan synthesis and proteoglycan breakdown of bovine articular cartilage in vitro.
Neidel J; Zeidler U
Agents Actions; 1993 May; 39(1-2):82-90. PubMed ID: 8285145
[TBL] [Abstract][Full Text] [Related]
5. Induction of articular cartilage degradation by recombinant interleukin 1 alpha and 1 beta.
Smith RL; Allison AC; Schurman DJ
Connect Tissue Res; 1989; 18(4):307-16. PubMed ID: 2787228
[TBL] [Abstract][Full Text] [Related]
6. Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo.
van Beuningen HM; van der Kraan PM; Arntz OJ; van den Berg WB
Ann Rheum Dis; 1993 Mar; 52(3):185-91. PubMed ID: 8484670
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation.
Chandrasekhar S; Harvey AK
Biochem Biophys Res Commun; 1988 Dec; 157(3):1352-9. PubMed ID: 3144973
[TBL] [Abstract][Full Text] [Related]
8. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage.
Hardingham TE; Bayliss MT; Rayan V; Noble DP
Br J Rheumatol; 1992; 31 Suppl 1():1-6. PubMed ID: 1532522
[TBL] [Abstract][Full Text] [Related]
9. Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose.
Malfait AM; Verbruggen G; Veys EM; Lambert J; De Ridder L; Cornelissen M
J Rheumatol; 1994 Feb; 21(2):314-20. PubMed ID: 8182643
[TBL] [Abstract][Full Text] [Related]
10. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of proteoglycan synthesis in explants of porcine articular cartilage by recombinant osteogenic protein-1 (bone morphogenetic protein-7).
Lietman SA; Yanagishita M; Sampath TK; Reddi AH
J Bone Joint Surg Am; 1997 Aug; 79(8):1132-7. PubMed ID: 9278071
[TBL] [Abstract][Full Text] [Related]
12. The role and content of endogenous insulin-like growth factor-binding proteins in bovine articular cartilage.
Morales TI
Arch Biochem Biophys; 1997 Jul; 343(2):164-72. PubMed ID: 9224726
[TBL] [Abstract][Full Text] [Related]
13. TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors.
Gendron C; Kashiwagi M; Hughes C; Caterson B; Nagase H
FEBS Lett; 2003 Dec; 555(3):431-6. PubMed ID: 14675751
[TBL] [Abstract][Full Text] [Related]
14. Effect of interleukin-1 and insulin like growth factor-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture.
Fosang AJ; Tyler JA; Hardingham TE
Matrix; 1991 Feb; 11(1):17-24. PubMed ID: 2027327
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1.
Taskiran D; Stefanovic-Racic M; Georgescu H; Evans C
Biochem Biophys Res Commun; 1994 Apr; 200(1):142-8. PubMed ID: 7513156
[TBL] [Abstract][Full Text] [Related]
17. The effect of naproxen and interleukin-1 on proteoglycan catabolism and on neutral metalloproteinase activity in normal articular cartilage in vitro.
Glazer PA; Rosenwasser MP; Ratcliffe A
J Clin Pharmacol; 1993 Feb; 33(2):109-14. PubMed ID: 8440758
[TBL] [Abstract][Full Text] [Related]
18. IL-1 beta and TGF-beta 1 modulate the sulphation grade of chondro-disaccharides in porcine articular cartilage: a capillary electrophoresis study.
Zanni M; Tamburro A; Rotilio D
J Lipid Mediat Cell Signal; 1995 Jul; 12(1):29-44. PubMed ID: 7551687
[TBL] [Abstract][Full Text] [Related]
19. Effects of catabolic and anabolic cytokines on proteoglycan biosynthesis in young, old and osteoarthritic canine cartilage.
Venn G; Lauder RM; Hardingham TE; Muir H
Biochem Soc Trans; 1990 Oct; 18(5):973-4. PubMed ID: 2083777
[No Abstract] [Full Text] [Related]
20. Inhibition of interleukin 1 beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27391.
Seed MP; Ismaiel S; Cheung CY; Thomson TA; Gardner CR; Atkins RM; Elson CJ
Ann Rheum Dis; 1993 Jan; 52(1):37-43. PubMed ID: 8427512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
